These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30341928)

  • 21. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
    Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
    Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
    Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Wenger N; Sebastian T; Beer JH; Mazzolai L; Aujesky D; Hayoz D; Engelberger RP; Korte W; Voci D; Kucher N; Barco S; Spirk D
    Thromb Res; 2022 Dec; 220():65-71. PubMed ID: 36272334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study protocol for a multicentre implementation trial of monotherapy anticoagulation to expedite home treatment of patients diagnosed with venous thromboembolism in the emergency department.
    Kline J; Adler D; Alanis N; Bledsoe J; Courtney D; D'Etienne J; B Diercks D; Garrett J; Jones AE; MacKenzie D; Madsen T; Matuskowitz A; Mumma B; Nordenholz K; Pagenhardt J; Runyon M; Stubblefield W; Willoughby C
    BMJ Open; 2020 Oct; 10(10):e038078. PubMed ID: 33004396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus on weekdays.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Morita Y; Tada T; Izumi T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
    J Thromb Thrombolysis; 2021 Apr; 51(3):779-788. PubMed ID: 32728908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article.
    Cox JB; Weaver KJ; Neal DW; Jacob RP; Hoh DJ
    J Neurosurg Spine; 2014 Oct; 21(4):677-84. PubMed ID: 25105337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study.
    Okumura Y; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Hirayama A;
    BMJ Open; 2018 Jun; 8(6):e020286. PubMed ID: 29934383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study.
    Spencer FA; Gore JM; Lessard D; Douketis JD; Emery C; Goldberg RJ
    Arch Intern Med; 2008 Feb; 168(4):425-30. PubMed ID: 18299499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Obesity Associated With Increased Risk of Deep Vein Thrombosis or Pulmonary Embolism After Hip and Knee Arthroplasty? A Large Database Study.
    Sloan M; Sheth N; Lee GC
    Clin Orthop Relat Res; 2019 Mar; 477(3):523-532. PubMed ID: 30624321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial.
    Kline JA; Adler DH; Alanis N; Bledsoe JR; Courtney DM; d'Etienne JP; Diercks DB; Garrett JS; Jones AE; Mackenzie DC; Madsen T; Matuskowitz AJ; Mumma BE; Nordenholz KE; Pagenhardt J; Runyon MS; Stubblefield WB; Willoughby CB
    Circ Cardiovasc Qual Outcomes; 2021 Jul; 14(7):e007600. PubMed ID: 34148351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.
    Beyer-Westendorf J; Schellong SM; Gerlach H; Rabe E; Weitz JI; Jersemann K; Sahin K; Bauersachs R;
    Lancet Haematol; 2017 Mar; 4(3):e105-e113. PubMed ID: 28219692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of hospital readmission in patients diagnosed with DVT and PE: clinical burden of recurrent events.
    Nutescu EA; Crivera C; Schein JR; Bookhart BK
    Int J Clin Pract; 2015 Mar; 69(3):321-7. PubMed ID: 25395271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018.
    Lutsey PL; Walker RF; MacLehose RF; Norby FL; Evensen LH; Alonso A; Zakai NA
    J Am Heart Assoc; 2021 Oct; 10(20):e020428. PubMed ID: 34622678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.
    Fang MC; Fan D; Sung SH; Witt DM; Schmelzer JR; Steinhubl SR; Yale SH; Go AS
    Med Care; 2017 Dec; 55(12):e137-e143. PubMed ID: 29135777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family history of venous thromboembolism predicts the diagnosis of acute pulmonary embolism in the emergency department.
    Kelly C; Agy C; Carlson M; Steenblik J; Bledsoe J; Hartsell S; Madsen T
    Am J Emerg Med; 2018 Sep; 36(9):1550-1554. PubMed ID: 29338966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study.
    Turpie AGG; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Ageno W
    Thromb Res; 2017 Jul; 155():23-27. PubMed ID: 28477534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency Department Discharge of Pulmonary Embolus Patients.
    Frank Peacock W; Coleman CI; Diercks DB; Francis S; Kabrhel C; Keay C; Kline JA; Manteuffel J; Wildgoose P; Xiang J; Singer AJ
    Acad Emerg Med; 2018 Sep; 25(9):995-1003. PubMed ID: 29757489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece.
    Gourzoulidis G; Kourlaba G; Kakisis J; Matsagkas M; Giannakoulas G; Gourgoulianis KI; Vassilakopoulos T; Maniadakis N
    Clin Drug Investig; 2017 Sep; 37(9):833-844. PubMed ID: 28608312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications, applications, and outcomes of inferior vena cava filters for venous thromboembolism in Japanese patients.
    Yamashita Y; Unoki T; Takagi D; Hamatani Y; Ishii M; Iguchi M; Ogawa H; Masunaga N; Wada H; Hasegawa K; Abe M; Akao M
    Heart Vessels; 2016 Jul; 31(7):1084-90. PubMed ID: 26135928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.